International HealthCare
Private Company
Funding information not available
Overview
International HealthCare (IHC) is a privately held, revenue-generating contract research organization (CRO) offering comprehensive clinical trial management and regulatory services. With a global operational footprint spanning the US, Europe, Latin America, and Canada, IHC leverages experienced staff and technology to accelerate clinical programs for its clients in the drug, device, and consumer healthcare sectors. The company emphasizes a history of delivering studies with faster completion, lower cost, and greater data integrity, positioning itself as a partner for sponsors seeking efficient product development and regulatory approval.
Technology Platform
Utilizes sophisticated state-of-the-art technology including Electronic Data Capture (EDC), secure large-file transfer systems, and data analytics to support risk-based monitoring, adaptive trial designs, and ensure data integrity.
Opportunities
Risk Factors
Competitive Landscape
IHC operates in the highly competitive global CRO market, competing against large, publicly-traded firms (e.g., IQVIA, ICON, LabCorp) with vast resources and broad portfolios, as well as many smaller, specialized CROs. Its differentiation is based on claimed expertise in medical devices and OTC switches, personalized support, and a global but flexible operational model.